- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 276 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- January 2020
- 100 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- October 2024
- 81 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Book
- May 2020
North America
The Controlled Substance market is a subset of the Pharmaceutical industry that focuses on the production and distribution of drugs that are subject to government regulation due to their potential for abuse. These drugs are classified as Schedule I, II, III, IV, and V, depending on their potential for abuse and accepted medical use. The Controlled Substance market is highly regulated, with strict rules and regulations governing the production, distribution, and sale of these drugs.
The Controlled Substance market is dominated by large pharmaceutical companies, such as Pfizer, Merck, and Johnson & Johnson. Other major players in the market include GlaxoSmithKline, Novartis, and Sanofi. Smaller companies, such as Mylan and Teva Pharmaceuticals, also have a presence in the market. Show Less Read more